Nurix Therapeutics seeks a scientific leader to define and drive our in vitro screening and pharmacological characterization for Degrader Antibody Conjugates (DACs). This hands-on leadership role requires building assays, interpreting data, and guiding cross-functional teams from primary screening through candidate selection.
The ideal candidate will design, execute, and analyze cellular assays to characterize DAC activity, work with discovery biology, chemistry, and DMPK, and mentor scientists
#J-18808-LjbffrSenior Scientist, Degrader Antibody Conjugates Pharmacology in san francisco at Unknown Company
This position is listed as full time and onsite.